FR2258841B1 - - Google Patents

Info

Publication number
FR2258841B1
FR2258841B1 FR7402810A FR7402810A FR2258841B1 FR 2258841 B1 FR2258841 B1 FR 2258841B1 FR 7402810 A FR7402810 A FR 7402810A FR 7402810 A FR7402810 A FR 7402810A FR 2258841 B1 FR2258841 B1 FR 2258841B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7402810A
Other languages
French (fr)
Other versions
FR2258841A1 (ja
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Produits Chimiques Ugine Kuhlmann
Ugine Kuhlmann SA
Original Assignee
Produits Chimiques Ugine Kuhlmann
Ugine Kuhlmann SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Produits Chimiques Ugine Kuhlmann, Ugine Kuhlmann SA filed Critical Produits Chimiques Ugine Kuhlmann
Priority to FR7402810A priority Critical patent/FR2258841B1/fr
Priority to NL7500613A priority patent/NL7500613A/xx
Priority to DE19752503136 priority patent/DE2503136A1/de
Priority to LU71739A priority patent/LU71739A1/xx
Priority to GB357975A priority patent/GB1495665A/en
Priority to BE152800A priority patent/BE824885A/xx
Publication of FR2258841A1 publication Critical patent/FR2258841A1/fr
Application granted granted Critical
Publication of FR2258841B1 publication Critical patent/FR2258841B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7402810A 1974-01-29 1974-01-29 Expired FR2258841B1 (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR7402810A FR2258841B1 (ja) 1974-01-29 1974-01-29
NL7500613A NL7500613A (nl) 1974-01-29 1975-01-20 Werkwijze ter bereiding van een geneesmiddel, zo gevormd geneesmiddel en werkwijze ter berei- ding van daartoe geschikte geneeskrachtige ver- bindingen.
DE19752503136 DE2503136A1 (de) 1974-01-29 1975-01-27 5-methylthiopyrimidine, die als antidiabetische und hypocholesterinaemische arzneimittel geeignet sind
LU71739A LU71739A1 (ja) 1974-01-29 1975-01-28
GB357975A GB1495665A (en) 1974-01-29 1975-01-28 Pyrimidines
BE152800A BE824885A (fr) 1974-01-29 1975-01-28 Nouvelles methylthio-5 pyrimidines utilisables comme medicaments antidiabetiques et hypochlolesterolemiants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7402810A FR2258841B1 (ja) 1974-01-29 1974-01-29

Publications (2)

Publication Number Publication Date
FR2258841A1 FR2258841A1 (ja) 1975-08-22
FR2258841B1 true FR2258841B1 (ja) 1977-11-04

Family

ID=9134107

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7402810A Expired FR2258841B1 (ja) 1974-01-29 1974-01-29

Country Status (6)

Country Link
BE (1) BE824885A (ja)
DE (1) DE2503136A1 (ja)
FR (1) FR2258841B1 (ja)
GB (1) GB1495665A (ja)
LU (1) LU71739A1 (ja)
NL (1) NL7500613A (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632823B1 (en) 1997-12-22 2003-10-14 Merck & Co., Inc. Substituted pyridine compounds useful as modulators of acetylcholine receptors
NZ540612A (en) 2003-01-14 2008-02-29 Arena Pharm Inc 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
DOP2006000010A (es) * 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
EP2619198A1 (en) 2010-09-22 2013-07-31 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
EP4445956A2 (en) 2015-01-06 2024-10-16 Arena Pharmaceuticals, Inc. Compound for use in treating conditions related to the s1p1 receptor
WO2016209809A1 (en) 2015-06-22 2016-12-29 Arena Pharmaceuticals, Inc. Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid(compound1) for use in sipi receptor-associated disorders
WO2018151873A1 (en) 2017-02-16 2018-08-23 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis

Also Published As

Publication number Publication date
BE824885A (fr) 1975-07-28
FR2258841A1 (ja) 1975-08-22
GB1495665A (en) 1977-12-21
DE2503136A1 (de) 1975-07-31
LU71739A1 (ja) 1975-06-24
NL7500613A (nl) 1975-07-31

Similar Documents

Publication Publication Date Title
AU495920B2 (ja)
AU7138274A (ja)
AU7099174A (ja)
BG20443A1 (ja)
AU479725A (ja)
AU481082A (ja)
AU481101A (ja)
AU481340A (ja)
AU481457A (ja)
AU481580A (ja)
AU482019A (ja)
AU482110A (ja)
AU482332A (ja)
AU480580A (ja)
AU480469A (ja)
BG20001A1 (ja)
BG19607A1 (ja)
BG19772A1 (ja)
BG19828A1 (ja)
BG19873A1 (ja)
BG19954A1 (ja)
BG19982A1 (ja)
BG22732A1 (ja)
BG20159A1 (ja)
BG22484A1 (ja)

Legal Events

Date Code Title Description
TP Transmission of property
CD Change of name or company name
TP Transmission of property
ST Notification of lapse